SCHEMBL654332

SCHEMBL654332

CCCCCCCCP(=O)(O)OC

nearest known ligand 0.67

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
LPAR3 Q9UBY5 6/20 0.60
LPAR2 Q9HBW0 3/20 0.60
FAAH O00519 1/20 0.57
CETP P11597 5/20 0.51
LPAR1 Q92633 2/20 0.48
TRPM8 Q7Z2W7 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL652194 1.00 LPAR3 (0.60) LPAR3LPAR2FAAHCETPLPAR1
SCHEMBL653716 1.00 LPAR3 (0.60) LPAR3LPAR2FAAHCETPLPAR1
SCHEMBL9078658 1.00 LPAR3 (0.60) LPAR3LPAR2FAAHCETPLPAR1
SCHEMBL652448 1.00 LPAR3 (0.60) LPAR3LPAR2FAAHCETPLPAR1
SCHEMBL20553273 1.00 LPAR3 (0.60) LPAR3LPAR2FAAHCETPLPAR1
SCHEMBL654670 1.00 LPAR3 (0.60) LPAR3LPAR2FAAHCETPLPAR1
SCHEMBL9080697 1.00 LPAR3 (0.60) LPAR3LPAR2FAAHCETPLPAR1
SCHEMBL14883684 1.00 LPAR3 (0.60) LPAR3LPAR2FAAHCETPLPAR1
SCHEMBL655424 1.00 LPAR3 (0.60) LPAR3LPAR2FAAHCETPLPAR1
SCHEMBL28965549 1.00 LPAR3 (0.60) LPAR3LPAR2FAAHCETPLPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7314850-B2 Methods and compositions for treating subterranean formations with gelled hydrocarbon fluids HALLIBURTON ENERGY SERVICES, INC. (US) 2008-01-01 US claimed
US-20210030773-A1 PHOSPHATE DERIVATIVES AND USE THEREOF Shanghai Shengyue Pharmaceutical Technology Co., Ltd. (CN) 2021-02-04 US disclosed
US-8710120-B2 Cross-linkable compositions WACKER CHEMIE AG (DE) 2014-04-29 US disclosed
EP-2486097-B1 CROSSLINKABLE COMPOSITIONS WACKER CHEMIE AG (DE) 2013-07-24 EP disclosed
US-8399548-B2 Crosslinkable materials based on organosilicon compounds WACKER CHEMIE AG (DE) 2013-03-19 US disclosed
EP-2486097-A1 CROSS-LINKABLE COMPOSITIONS Wacker Chemie AG (DE) 2012-08-15 EP disclosed
US-20120202919-A1 CROSS-LINKABLE COMPOSITIONS WACKER CHEMIE AG (DE) 2012-08-09 US disclosed
US-8119575-B2 Gelation in presence of iron or aluminum salt of phosphonic acid or dialkylphosphinic acid HALLIBURTON ENERGY SERVICES, INC. (US) 2012-02-21 US disclosed
WO-2011042340-A1 CROSS-LINKABLE COMPOSITIONS WACKER CHEMIE AG (DE) 2011-04-14 WO disclosed
EP-2172525-B1 Crosslinkable materials based on organosilicon compounds WACKER CHEMIE AG (DE) 2011-03-23 EP disclosed
EP-1559867-A1 Methods and compositions for treating subterranean formations with gelled hydrocarbon fluids Halliburton Energy Services, Inc. (US) 2005-08-03 EP disclosed
US-20040214728-A1 Methods and compositions for treating subterranean formations with gelled hydrocarbon fluids HALLIBURTON ENERGY SERVICES, INC. 2004-10-28 US disclosed
EP-1236863-B1 Gelled hydrocarbon fluids for treating subterranean formations HALLIBURTON ENERGY SERV INC (US) 2004-05-12 EP disclosed
US-20030228985-A1 Methods and compositions for treating subterranean formations with gelled hydrocarbon fluids HALLIBURTON ENERGY SERVICES, INC. 2003-12-11 US disclosed
US-6544934-B2 Additive for breaking a gel of a hydrocarbon liquid and a ferric iron salt of a phosphonic acid ester, comprising a water soluble reducing agent for the ferric salt HALLIBURTON ENERGY SERVICES, INC. 2003-04-08 US disclosed
US-6511944-B2 Containing group 3, group 8 compounds; fracturing HALLIBURTON ENERGY SERVICES, INC. 2003-01-28 US disclosed
US-20020165101-A1 Methods and compositions for treating subterranean formations with gelled hydrocarbon fluids HALLIBURTON ENERGY SERVICES, INC. 2002-11-07 US disclosed
US-20020160921-A1 Methods and compositions for treating subterranean formations with gelled hydrocarbon fluids HALLIBURTON ENERGY SERVICES, INC. 2002-10-31 US disclosed
EP-1236863-A1 Gelled hydrocarbon fluids for treating subterranean formations Halliburton Energy Services, Inc. (US) 2002-09-04 EP disclosed
EP-1234948-A1 Treating subterranean formations with gelled hydrocarbon fluids Halliburton Energy Services, Inc. (US) 2002-08-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210030773-A1 PHOSPHATE DERIVATIVES AND USE THEREOF CXCL12, MIF, FGF23 LPAR3 1079/4885LPAR2 1383/4885FAAH 4121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.